It seems like there is no institution that is more criticized in science than that of the peer-review system — an no one that is less mutable. While published paper evaluation metrics are being revised (such as the recently introduced PLoS article level metrics, or the Australian National Health and Medical Research Council abandonment of […]
I’ve been cleaning out my Gmail from attachment-emails recently. (Why do people continue to send me video files when there’s YouTube?) Anyhow, Mickey Kosloff sent me this. In this pic, form meet function, being concise and to the point, as a good grant application should be.
One problem that I am facing is convincing colleagues of the utility of an Open Access publication. The usual arguments: more visibility, retention of the right to re-use material, the Greater Good, taxpayer access to taxpayer-funded research and so on don’t stick very well when faced with a $1500-$2500 or higher publication fee. These can […]
Sooo… NIH and NSF started Tweeting. Nice. A good way to keep up with grant programs, funding opportunities, yadda yadda. Here’s my @ tweet : @NIH protein catalytic site evolution health implic: good for drug design. Young scientist, need $0.7M 2010-2013, 2xpostdocs+cluster+travel. Prev pubs: http://is.gd/vnPN; kthxbi I hope I won’t get killed at the renewal…
Following Shirley Wu’s excellent post on the stimulus money at the NIH, I decided to do my bit, and post some bioinformatically relevant programs from the Challenge Grants. I am defining bioinformatics rather narrowly here, and excluding most biomedical informatics, imaging technologies, clinical data management, etc. Also, many other topics would be supported to some […]
(Continued from “On Microbial Sequencing“). Well, it’s really been a great meeting. The biology of pathogens, parasites and symbionts is amazing. Historically, the microbes that chiefly interested us were one of those three: those that causes disease in humans, animals (focus on domesticated animals), plants (again, mostly domesticated). However, as we are (alas, too slowly) […]
